U.S., Dec. 17 -- ClinicalTrials.gov registry received information related to the study (NCT07285629) titled 'Safety and Efficacy of Klotho and Follistatin Gene Therapy' on Nov. 27.
Brief Summary: The purpose of this study is to investigate the safety and efficacy of a combination klotho and follistatin gene therapy, delivered via a nonviral plasmid in healthy adult volunteers. Additionally, this study seeks to understand the cognitive and health benefits of this gene therapy.
Study Start Date: Dec. 06
Study Type: INTERVENTIONAL
Condition:
Healthy Adults
Intervention:
GENETIC: Follistatin and klotho gene therapy
Injection of nonviral plasmid-delivered follistatin and klotho gene therapy
Recruitment Status: NOT_YET_RECRUITING
Sponso...